Services

Our Cause

As biopharmaceutical companies adopt a leaner model for producing the drugs of tomorrow and virtual companies abound to take advantage of savings through outsourcing, IAS stands poised to continue providing efficient and economical contract DMPK (drug metabolism and pharmacokinetics) and analytical chemistry services to these organizations. The intense pressure to advance preclinical compounds demands that a CRO be a responsive partner, and IAS is just this type of company: we offer a boutique-level of attention to our clients while providing cost-effective and timely DMPK data. As your partner in navigating the preclinical gauntlet we are committed to reducing the time and investment required to drive your compounds from the bench-top to the clinic.

Experience and Expertise

The management and staff at IAS bring a breadth of biopharmaceutical and CRO experience to the analytical knowledge base and business processes of IAS. Our scientific staff represents a blend of cross-discipline experience that allows different aspects of the same project to be bridged seamlessly. It is through this breadth and blend of experience that we can accelerate your compounds from early stage research to IND activities. As a member of your project we will apply our knowledge to assess the specific properties of a compound that may improve or tarnish its chances of being an IND candidate. You can rely on us to share these insights to inform and advance your research programs.